BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
We present Q3 FY22 preview of our mid-cap coverage universe. We have divided our coverage into three sections: 1. specialty chemicals, 2. specialty ingredients and 3. other mid-caps.
Overall, we believe that the strong growth trajectory should be maintained in specialty chemicals as well as select specialty ingredients companies. Elevated input costs, freight and power costs should continue to affect profitability of the chemicals companies to an extent in Q3 FY22 also.
However, companies with core focus on specialty businesses should be able to navigate through these challenges in a relatively better manner.
In our other midcap universe La Opala RG Ltd. is expected to deliver strong growth in Q3 FY22 on account of festive sales. Q2 FY22 was the strongest ever quarter for La Opala. We expect absolute revenue to be higher by ~19% QoQ in Q3 FY22.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR